Brief: Zymeworks Inc Expects Total Revenue, Including Collaboration Revenue From Yupelri, For 2026 To Be Between $278 Million And $292 Million
28/09/2026 11:05
BRIEF-Zymeworks Inc Expects Total Revenue, Including Collaboration Revenue From Yupelri, For 2026 To Be Between $278 Million And $292 Million Sept 28 (Reuters) - Zymeworks Inc ZYME.O:
EXPECTS TOTAL REVENUE, INCLUDING COLLABORATION REVENUE FROM YUPELRI, FOR 2026 TO BE BETWEEN $278 MILLION AND $292 MILLION
ZYMEWORKS OUTLOOK 2026 ADJUSTED EBITDA TO BE BETWEEN $114 MILLION AND $128 MILLION
FY2026 REVENUE VIEW $311.7 MILLION -- LSEG IBES DATA
Source text: ID:nGNEbwScZx
Further company coverage: ZYME.O
(Reporting by Tyakshi Singh)
((Tyakshi.Singh@thomsonreuters.com;))
Recent news on Zymeworks
See all newsUS STOCKS ON THE MOVE-Huron Consulting, RingCentral, Selective Insurance
U.S. STOCKS ON THE MOVE-Huron Consulting, Crown Castle, Bloom Energy
US STOCKS ON THE MOVE-Booz Allen Hamilton, SLB, Deckers Outdoor
US STOCKS ON THE MOVE-American Express, Gorman-Rupp, Moderna
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug